59 reports

  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • Latin America
  • Mexico
  • North America
  • Alere Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • China
  • East Asia
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • Brazil
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • India
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • France
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • Beckman Coulter, Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • East Asia
  • South Korea
  • Abbott Laboratories, Inc.
  • Alere Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • Spain
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

THIS IS BECAUSE TOO MUCH LDL RESULTS IN A BUILD-UP OF CHOLESTEROL IN ARTERIES, WHICH CAN LEAD TO HEART ATTACKS AND STROKES.

  • In Vitro Diagnostic Reagent
  • India
  • Russia
  • Forecast
  • Market Size
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • Russia
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

THIS IS BECAUSE TOO MUCH LDL RESULTS IN A BUILD-UP OF CHOLESTEROL IN ARTERIES, WHICH CAN LEAD TO HEART ATTACKS AND STROKES.

  • In Vitro Diagnostic Reagent
  • Latin America
  • Mexico
  • North America
  • Forecast
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

THIS IS BECAUSE TOO MUCH LDL RESULTS IN A BUILD-UP OF CHOLESTEROL IN ARTERIES, WHICH CAN LEAD TO HEART ATTACKS AND STROKES.

  • In Vitro Diagnostic Reagent
  • Eastern Europe
  • Russia
  • Forecast
  • bioMerieux S.A.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

THIS IS BECAUSE TOO MUCH LDL RESULTS IN A BUILD-UP OF CHOLESTEROL IN ARTERIES, WHICH CAN LEAD TO HEART ATTACKS AND STROKES.

  • In Vitro Diagnostic Reagent
  • East Asia
  • Forecast
  • Market Size
  • Beckman Coulter, Inc.

Chan School of Public Health suggests that major changes in Chinese society may have contributed to the surge in cardiovascular diseases, which can lead to heart attacks and stroke.

  • HPV Testing
  • In Vitro Diagnostic Reagent
  • China
  • East Asia
  • OriGene Technologies, Inc.
  • ATOMORAPID - HEART ATTACK - PRODUCT DESCRIPTION
  • ATOMORAPID - HEART ATTACK - PRODUCT STATUS

It also develops integrated diagnostic support for handy measuring instruments and disposable chip for diagnosis of heart attacks.

  • Antimalarials
  • Clinical Trial
  • In Vitro Diagnostic Reagent
  • United States
  • bioMerieux S.A.
  • DIAGNOSTIC BLOOD TEST - HEART ATTACK - PRODUCT DESCRIPTION
  • PREDX DRS - FIRST TIME HEART ATTACK - PRODUCT DESCRIPTION

Share Buyback Comments for the occurrence of a heart attack, stroke, or cardiovascular death within one year.

  • Clinical Trial
  • Healthcare
  • In Vitro Diagnostic Reagent
  • United States
  • Pfizer Inc.
  • TROPONIN-I TEST - PRODUCT DESCRIPTION

Troponins are considered the " gold-standard" cardiac biomarkers for the diagnosis and management of myocardial infarctions (heart attack).

  • In Vitro Diagnostic Reagent
  • Medical Device
  • United States
  • Litigation And Patent
  • CardioGenics Holdings Inc.

Prioritising people presenting with a heart attack over those with non-cardiac chest pain is one of the biggest challenges A& E doctors face there are around ##, ## heart attacks each year in the UK, but around ## million people come to A&

  • In Vitro Diagnostic Reagent
  • Laboratory
  • United Kingdom
  • World
  • Randox Laboratories Ltd.

Patients with a history of heart attacks or strokes require regular testing of cholesterol to monitor the effectiveness of their treatments.

  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • North America
  • United States
  • Roche Group
  • Indication
  • PSA-SP ASSAY - HEART FAILURE - PRODUCT DESCRIPTION

He is Director of the Christchurch Heart Institute (CHI), University of Otago and Professor of Cardiovascular Studies for the National Heart Foundation of New Zealand.

  • Chronic Disease
  • Diagnostics
  • Heart Failure
  • In Vitro Diagnostic Reagent
  • New Zealand

According to the World Health Organization, there are ##. ## million deaths per year due to ischemic heart disease. ## In the U. S. alone, ##, ## patients suffer from a heart attack every year. ## A heart attack is an urgent, time-critical emergency t

  • Clinical Diagnostic
  • In Vitro Diagnostic Reagent
  • Opioid
  • United States
  • Ortho-Clinical Diagnostics, Inc.

Heart disease is the number one cause of death in the world today. ## Due to the acute nature and rapid progression of heart disease, accurate and quantitative diagnostic assays have been developed to detect the presence of clinically proven biomarkers.

  • Cardiovascular Disease
  • Hospital
  • In Vitro Diagnostic Reagent
  • United States
  • Singulex, Inc.

The PLAC ELISA Test aids in assessing risk for both coronary heart disease (CHD) and ischemic stroke associated with atherosclerosis and designed to provide information, over and above traditional risk factors, such as cholesterol levels, to help identify individuals at increased risk of su

  • In Vitro Diagnostic Reagent
  • Medical Device
  • United States
  • M&A
  • OriGene Technologies, Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • Medical Device
  • Italy
  • Market Segment
  • Ortho-Clinical Diagnostics, Inc.
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

THIS IS BECAUSE TOO MUCH LDL RESULTS IN A BUILD-UP OF CHOLESTEROL IN ARTERIES, WHICH CAN LEAD TO HEART ATTACKS AND STROKES.

  • In Vitro Diagnostic Reagent
  • Medical Device
  • Canada
  • North America
  • Ortho-Clinical Diagnostics, Inc.

Results from ongoing trials and other highlights ACZ## (canakinumab) CANTOS phase III study met its primary endpoint with a statistically significant ##% reduction of MACE in people with a prior heart attack and inflammatory atherosclerosis.

  • Clinical Trial
  • Immunodiagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Novartis AG
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

THIS IS BECAUSE TOO MUCH LDL RESULTS IN A BUILD-UP OF CHOLESTEROL IN ARTERIES, WHICH CAN LEAD TO HEART ATTACKS AND STROKES.

  • In Vitro Diagnostic Reagent
  • Medical Device
  • Australasia
  • Australia
  • Oceania
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

This is because too much LDL results in a build-up of cholesterol in arteries, which can lead to heart attacks and strokes.

  • In Vitro Diagnostic Reagent
  • Medical Device
  • East Asia
  • Japan
  • Sysmex Corporation
  • 2.3 DEFINITIONS OF MARKETS COVERED IN THE REPORT

PATIENTS NOT HAVING A HEART ATTACK) BEING RELEASED FROM A& E MUCH EARLIER.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • Infectious Disease
  • Forecast
  • Market Size

THE PRIMARY ENDPOINT WAS DEFINED AS TIME TO FIRST OCCURRENCE OF CARDIOVASCULAR DEATH, NON-FATAL HEART ATTACK OR NON-FATAL STROKE.

  • Hospital
  • In Vitro Diagnostic Reagent
  • Medical Device
  • North America
  • Forecast

THE PRIMARY ENDPOINT WAS DEFINED AS TIME TO FIRST OCCURRENCE OF CARDIOVASCULAR DEATH, NON-FATAL HEART ATTACK OR NON-FATAL STROKE.

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • North America
  • United States
  • Thermo Fisher Scientific, Inc.